All Stories

  1. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

    Article • ClinicoEconomics and Outcomes Research, March 2018, Dove Medical Press

    ISABEL ALVAREZ LOPEZ, Javier Mar, Javier Mar

  2. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases

    Article • F1000Research, August 2017, Faculty of 1000, Ltd.

    Dr Marta Fernandez-Mercado, ISABEL ALVAREZ LOPEZ